Studies indicated that downregulating PRMT1 levels effectively arrested the cell cycle’s progression from the G1 to S phase in glioma cells exhibiting high PRMT1 levels, leading to the inhibition of proliferation and induction of apoptosis [113]. Here, PRMT1 is linked to glioma.